Crossmark

Erlotinib and gefitinib responsiveness in head and neck cancer cell lines—a comparing analysis with cetuximab

Crossref DOI link: https://doi.org/10.1007/s00784-015-1566-5

Published Online: 2015-08-23

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hartmann, Stefan

Neckel, Norbert

Seher, Axel

Mutzbauer, Grit

Brands, Roman C.

Linz, Christian

Kübler, Alexander C.

Müller-Richter, Urs D. A.
License Information

Text and Data Mining valid from 2015-08-23